/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.
Coeptis Therapeutics (COEP) Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Cancers: Coeptis NASDAQ: COEP
/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today.
Coeptis Therapeutics Partners with VyGen-Bio, Inc to Co-develop Two Assets Designed to Improve the Treatment of CD38-Related Cancers prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.